Selecta Biosciences
Patents, Design & Utilities

Last updated:

List of all Selecta Biosciences patents 25 in total

Status Patent
Application
Utility: METHODS AND COMPOSITIONS FOR REDUCING IMMUNE RESPONSES AGAINST IMMUNOGLOBULIN PROTEASES External link
Filling date: 26 Sep 2025 Issue date: 5 May 2022
Grant
Utility: Methods providing a therapeutic macromolecule and synthetic nanocarriers comprising immunosuppressant locally and concomitantly to reduce both type I and type IV hypersensitivity External link
Filling date: 26 Sep 2025 Issue date: 12 Apr 2022
Application
Utility: METHODS OF ADMINISTERING IMMUNOSUPPRESSANTS HAVING A SPECIFIED PHARMACODYNAMIC EFFECTIVE LIFE AND THERAPEUTIC MACROMOLECULES FOR THE INDUCTION OF IMMUNE TOLERANCE External link
Filling date: 26 Sep 2025 Issue date: 10 Mar 2022
Grant
Utility: Methods for providing polymeric synthetic nanocarriers for generating antigen-specific tolerance immune responses External link
Filling date: 26 Sep 2025 Issue date: 1 Feb 2022
Application
Utility: METHODS AND COMPOSITIONS RELATED TO SYNTHETIC NANOCARRIERS External link
Filling date: 26 Sep 2025 Issue date: 7 Oct 2021
Application
Utility: METHODS AND COMPOSITIONS USING SYNTHETIC NANOCARRIERS COMPRISING IMMUNOSUPPRESSANT External link
Filling date: 26 Sep 2025 Issue date: 23 Sep 2021
Application
Utility: FORMULATIONS AND DOSES OF PEGYLATED URICASE External link
Filling date: 26 Sep 2025 Issue date: 24 Jun 2021
Application
Utility: METHODS AND COMPOSITIONS FOR TREATING LIVER DISEASES AND DISORDERS External link
Filling date: 26 Sep 2025 Issue date: 27 May 2021
Application
Utility: FORMULATIONS AND DOSES OF PEGYLATED URICASE External link
Filling date: 26 Sep 2025 Issue date: 24 Dec 2020
Application
Utility: METHODS AND COMPOSITIONS FOR ATTENUATED ANTI-VIRAL TRANSFER VECTOR IMMUNE RESPONSE External link
Filling date: 26 Sep 2025 Issue date: 17 Dec 2020
Application
Utility: NANOCARRIERS POSSESSING COMPONENTS WITH DIFFERENT RATES OF RELEASE External link
Filling date: 26 Sep 2025 Issue date: 17 Dec 2020
Application
Utility: METHODS FOR TREATMENT OF SUBJECTS WITH PREEXISTING IMMUNITY TO VIRAL TRANSFER VECTORS External link
Filling date: 26 Sep 2025 Issue date: 19 Nov 2020
Application
Utility: TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE OR PREVENT ANAPHYLAXIS IN RESPONSE TO A NON-ALLERGENIC ANTIGEN External link
Filling date: 26 Sep 2025 Issue date: 19 Nov 2020
Grant
Utility: Tolerogenic synthetic nanocarriers to reduce or prevent anaphylaxis in response to a non-allergenic antigen External link
Filling date: 26 Sep 2025 Issue date: 2 Jun 2020
Application
Utility: METHODS RELATED TO ADMINISTERING IMMUNOSUPPRESSANTS AND THERAPEUTIC MACROMOLECULES AT A REDUCED PHARMACODYNAMICALLY EFFECTIVE DOSE External link
Filling date: 26 Sep 2025 Issue date: 16 Apr 2020
Application
Utility: TOLEROGENIC SYNTHETIC NANOCARRIERS FOR GENERATING CD8+ REGULATORY T CELLS External link
Filling date: 26 Sep 2025 Issue date: 2 Apr 2020
Application
Utility: TOLEROGENIC SYNTHETIC NANOCARRIERS FOR ANTIGEN-SPECIFIC DELETION OF T EFFECTOR CELLS External link
Filling date: 26 Sep 2025 Issue date: 2 Apr 2020
Application
Utility: METHODS PROVIDING A THERAPEUTIC MACROMOLECULE AND SYNTHETIC NANOCARRIERS COMPRISING IMMUNOSUPPRESSANT LOCALLY AND CONCOMITANTLY TO REDUCE BOTH TYPE 1 AND TYPE IV HYPERSENSITIVITY External link
Filling date: 26 Sep 2025 Issue date: 12 Mar 2020
Application
Utility: METHODS COMPRISING DOSING COMBINATIONS FOR REDUCING UNDESIRED HUMORAL IMMUNE RESPONSES External link
Filling date: 26 Sep 2025 Issue date: 5 Mar 2020
Application
Utility: METHODS OF ADMINISTERING IMMUNOSUPPRESSANTS HAVING A SPECIFIED PHARMACODYNAMIC EFFECTIVE LIFE AND THERAPEUTIC MACROMOLECULES FOR THE INDUCTION OF IMMUNE TOLERANCE External link
Filling date: 26 Sep 2025 Issue date: 5 Mar 2020
Application
Utility: METHODS AND COMPOSITIONS OF MMA CONSTRUCTS AND VECTORS External link
Filling date: 26 Sep 2025 Issue date: 6 Feb 2020
Application
Utility: METHODS AND COMPOSITIONS OF OTC CONSTRUCTS AND VECTORS External link
Filling date: 26 Sep 2025 Issue date: 6 Feb 2020
Grant
Utility: Tolerogenic synthetic nanocarriers for generating CD8+ regulatory T cells External link
Filling date: 26 Sep 2025 Issue date: 15 Oct 2019
Grant
Utility: Methods related to administering immunosuppressants and therapeutic macromolecules at a reduced pharmacodynamically effective dose External link
Filling date: 26 Sep 2025 Issue date: 8 Oct 2019
Grant
Utility: Tolerogenic synthetic nanocarriers for antigen-specific deletion of T effector cells External link
Filling date: 26 Sep 2025 Issue date: 24 Sep 2019

Showing 1 to 25 of 25 patents.